MedPath

The genomics of taste receptors in the prevention of obesity

Conditions
obesity
Diet and Nutrition - Obesity
Registration Number
ACTRN12611000058976
Lead Sponsor
Dr Conor Delahunty
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

For these studies, we are specifically seeking individuals who are:

- 18 years or older
- Living in metropolitan Sydney
- Proficient in both written and spoken English
- Able to attend testing sessions between the hours of 9:00 am - 5:00pm Monday to Friday

Exclusion Criteria

For these studies we are specifically excluding individuals based upon the following criteria:

- Adults with known medical conditions known to affect weight (hyperthyroidism, Cushing syndrome etc)
- Individuals who are currently on, or have been on a diet, or specific dietary routine within the past 3 months
- Individuals who have experienced fluctuations in their weight by > 3 kg in the past 3 months
- Individuals who do not have adequate taste function
- Individuals who are restrained eaters (as defined by a score of > 12 on factor one of the eating attitudes test
- Individuals who are allergic to, or do not wish to consume dairy products
- Individuals over the age of 55 years
-Smokers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be taste sensitivity, as measured by detection and difference thresholds for sweet, fatty acid, salty, sour, umami and bitter tastes. Detection thresholds are considered the lowest amount of a tastant required for it to be detected, whereas difference thresholds are the concentration of tastant required for it be tasted as different from another sample at suprathreshold (above detection threshold) concentrations.[Taste thresholds, both detection and difference thresholds for these tastants will be measured in duplicate. Detection and difference thresholds will be measured on seperated occasions, seperated by 24 hours.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath